Related references
Note: Only part of the references are listed.Effects of Obesity on Overall Survival of Adults With Acute Myeloid Leukemia
Prajwal Dhakal et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse
Saiko Kurosawa et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)
Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine-based chemotherapy
Jing Ni et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting
Gunnar Juliusson et al.
BLOOD ADVANCES (2020)
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Rory M. Shallis et al.
BLOOD REVIEWS (2019)
Association between increased mutation rates in DNMT3A and FLT3-ITD and poor prognosis of patients with acute myeloid leukemia
Qiurong Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
FLT3 ligand plasma levels in acute myeloid leukemia
Pierre Peterlin et al.
HAEMATOLOGICA (2019)
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia
Paul Milne et al.
BLOOD ADVANCES (2019)
Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia
Pimjai Niparuck et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Impact of age on utilization and prognostic value of FLT3 and NPM1 testing in acute myeloid leukemia.
Claudio A. Mosse et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Impact of Race on Outcomes in Intermediate Risk Acute Myeloid Leukemia
Ivy Abraham et al.
BLOOD (2018)
Role of new Immunophenotypic Markers on Prognostic and Overall Survival of Acute Myeloid Leukemia: a Systematic Review and Meta-Analysis
A. F. O. Costa et al.
SCIENTIFIC REPORTS (2017)
Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis
Shufen Li et al.
SCIENTIFIC REPORTS (2017)
Analysis of the presence of FLT3 gene mutation and association with prognostic factors in adult and pediatric acute leukemia patients
Graciele Burnatt et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Prevalence and Clinical Significance of FLT3 Mutation Status in Acute Myeloid Leukemia Patients: A Multicenter Study
Jorge Cuervo-Sierra et al.
ARCHIVES OF MEDICAL RESEARCH (2016)
Acute Myeloid Leukemia: A Concise Review
Jennifer N. Saultz et al.
JOURNAL OF CLINICAL MEDICINE (2016)
High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia
Qiu-Ling Ma et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Prevalence Of FLT3 Mutations In Acute Myeloid Leukemia: A Multicenter Latin America Study
Jorge Cuervo-Sierra et al.
BLOOD (2013)
Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD
Hendrik J. M. de Jonge et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia
Maurizio Miglino et al.
LEUKEMIA & LYMPHOMA (2011)
Unfavorable-risk cytogenetics in acute myeloid leukemia
Wan-Jen Hong et al.
EXPERT REVIEW OF HEMATOLOGY (2011)
FLT3 and NPM1 mutations in Chinese patients with acute myeloid leukemia and normal cytogenetics
Lei Wang et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2010)
Use of Schoenfeld's global test to test the proportional hazards assumption in the Cox proportional hazards model: an application to a clinical study
W. W. M. Abeysekera et al.
JOURNAL OF THE NATIONAL SCIENCE FOUNDATION OF SRI LANKA (2009)
Prevalence of FMS-like tyrosine kinase 3/internal tandem duplication (FLT3/ITD+) in de novo acute myeloid leukemia patients categorized according to cytogenetic risk
Everson Augusto Krum et al.
SAO PAULO MEDICAL JOURNAL (2009)
Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia
Sebastian Scholl et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia
M. J. Greenwood et al.
LEUKEMIA & LYMPHOMA (2006)
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
C Barba et al.
LANCET (2004)
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics:: a study of the AML Study Group Ulm
S Fröhling et al.
BLOOD (2002)
Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease
M Nakao et al.
LEUKEMIA (2000)